Clinical Trial Update: Memantine - Communication Study [Phase 3]

View source ↗

Summary

A Phase 3 study of memantine for Alzheimer's disease has completed; the snippet provides no efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED